CPhI 2022, November 1-3

Are we going to be present at the next CPhI in Frankfurt? We are, of course! For three days, from November 1st to 3rd, we have the opportunity to reaf...

Read More

CF@BO 2021, September 10 – 11

ABOUT THE CH@BO n.11 ONLINE CONVENTION Because of the uncertainties still associated with the pandemic of SARS-COVID-19 the 11th edition of the Bologn...

Read More

Des-Methyl-Venlafaxine Salt

New Crystalline Forms of Des-Methyl-Venlafaxine Salt Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a gene...

Read More

IMAZAMOX: A Quest for Polymorphic Modifications of a Chiral and Racemic Herbicid

ABSTRACT: The structure−property relationships of new polymorphs of the chiral herbicide imazamox were investigated by X-ray diffraction, hot s...

Read More

Join us at CPhI Worldwide – Milan 2021

We invite you to join us at our booth n. 4H93 and learn more about our capabilities: Solid Form Development Crystallization Optimization Analytical Se...

Read More

Meet us at DCAT in New York!

We invite you to join us in our meeting room at the Intercontinental Suite #510/511 and learn more about our capabilities: Solid Form Development Crys...

Read More

Controlled Substances Studies & Analysis

PolyCrystalLine received the authorization N°101/2017 from the Italian Ministry of Healthfor the study and chemical/physical analysis of controlled s...

Read More

FDA – GMP

PolyCrystalLine SpA has been inspected by FDA and received the GMP certification from AIFA for the physico-chemical analyses. For any request please c...

Read More

MyCrystalPro: Our Online Portal

Polycrystalline can be entrusted with your most sensitive projects for method development and validation of API’s intermediates, raw materials and f...

Read More

PolyCrystalLine CDMO is on the way

PolyCrystalLine CDMO is on the way.Keep following us for the updates on the progress of our brand new facilities! Next generation of CR-DMO specialize...

Read More

Polymorphs of Dex-Lansoprazole

New Crystalline Forms of Dex-Lansoprazole Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a generic equivalent to Kap...

Read More

Highly Potent API

Polycrystalline is expanding its HPAPI offerings, up to OEB 5 level of containment for the synthesis, study and development of anti-cancer and cytotox...

Read More

FRENCH CERTIFICATION

PolyCrystalLine s.r.l. received the approval from French Health Ministry as a CRO for R&D activities, the French companies who use our services ca...

Read More

GMP CERTIFICATION

PolyCrystalLine received the audit from the Health Agency for the cGMP certification. PolyCrystalLine received the audit from the Health Agency for th...

Read More

Monodronic Acid Novel Form

PolyCrystalLine discovered a novel crystalline form of Minodronic Acid and filed a patent application. For additional information contact info@po...

Read More

Sostanze Altamente Attive: Rischi e Contenimento

Polycrystalline, CSV Life Science e Pharma-Hub organizzano la Giornata di Studio sul tema “SOSTANZE ALTAMENTE ATTIVE: RISCHI E CONTENIMENTO...

Read More